| [1] |
Nisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis [J]. Cochrane Database Syst Rev, 2016, 5: CD012179.
|
| [2] |
Kocbek V, Vouk K, Bersinger NA, et al. Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis [J]. J Mol Diagn, 2015, 17(3): 325-334.
|
| [3] |
Mosbah A, Nabiel Y, Khashaba E. Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis [J]. Int J Gynaecol Obstet, 2016, 134(3): 247-251.
|
| [4] |
Hoe E, Anderson J, Nathanielsz J, et al. The contrasting roles of Th17 immunity in human health and disease [J]. Microbiol Immunol, 2017, 61(2): 49-56.
|
| [5] |
Gershon RK, Kondo K. Infectious immunological tolerance [J]. Immunology, 1971, 21(6): 903-914.
|
| [6] |
Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells [J]. Immunity, 2013, 38(3): 414-423.
|
| [7] |
Landskron J, Helland Ø, Torgersen KM, et al. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients [J]. Cancer Immunol Immunother, 2015, 64(3): 337-347.
|
| [8] |
Chen C, Chen Z, Chen D, et al. Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer [J]. J Int Med Res, 2015, 43(2): 180-187.
|
| [9] |
Weed JC, Arquembourg PC. Endometriosis: can it produce an autoimmune response resulting in infertility? [J]. Clin Obstet Gynecol, 1980, 23(3): 885-893.
|
| [10] |
Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells [J]. Immunity, 2013, 38(3): 414-423.
|
| [11] |
Attaman JA, Stanic AK, Kim M, et al. The anti-inflammatory impact of omega-3 polyunsaturated fatty acids during the establishment of endometriosis - like lesions [J]. Am J Reprod Immunol, 2014, 72 (4): 392-402.
|
| [12] |
Hanada T, Tsuji S, Nakayama M, et al. Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis [J]. Reprod Biol Endocrinol, 2018, 16(1): 9.
|
| [13] |
Kresowik JD, Devor EJ, Van Voorhis BJ, et al. MicroRNA-31 is significantly elevated in both human endometrium and serum during the window of implantation: a potential biomarker for optimum receptivity [J]. Biol Reprod, 2014, 91(1): 17.
|
| [14] |
Gogacz M, Winkler I, Bojarska-Junak A, et al. T regulatory lymphocytes in patients with endometriosis [J]. Mol Med Rep, 2014, 10(2): 1072-1076.
|
| [15] |
Tanaka Y, Mori T, Ito F, et al. Exacerbation of endometriosis due to regulatory T-cell dysfunction [J]. J Clin Endocrinol Metab, 2017, 102(9): 3206-3217.
|
| [16] |
de Barros IBL, Malvezzi H, Gueuvoghlanian-Silva BY, et al. What do we know about regulatory T cells and endometriosis? A systematic review [J]. J Reprod Immunol, 2017, 120(1): 48-55.
|
| [17] |
Gueuvoghlanian-Silva BY, Bellelis P, Barbeiro DF, et al. Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease [J]. J Reprod Immunol, 2018, 126(1): 32-38.
|
| [18] |
Lehtimaki S, Lahesmaa R. Regulatory T cells control immune responses through their non-redundant tissue specific features [J]. Front Immunol, 2013, 4: 294.
|
| [19] |
杨娟，韦成厚，祝彩霞，等．卵巢子宫内膜异位囊肿患者免疫调节细胞Th17/Treg失衡的临床研究[J]．中山大学学报(医学科学版)，2017，38(1): 95-100.
|
| [20] |
Gogacz M, Winkler I, Bojarska-Junak A, et al. Increased percentage of Th17 cells in peritoneal fluid is associated with severity of endometriosis [J]. J Reprod Immunol, 2016, 117(1): 39-44.
|
| [21] |
La Rocca C, Carbone F, Longobardi S, et al. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus [J]. Immunol Lett, 2014, 162(1 Pt A): 41-48.
|
| [22] |
Krasimirova E, Velikova T, Ivanova-Todorova E, et al. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients [J]. World J Exp Med, 2017, 7(3): 84-96.
|
| [23] |
Lan YT, Fan XP, Fan YC, et al. Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value [J]. Medicine (Baltimore), 2017, 96(32): e7704.
|
| [24] |
Hanada T, Tsuji S, Nakayama M, et al. Suppressive regulatory T cells and latent transforming growth factor-β-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis [J]. Reprod Biol Endocrinol, 2018, 16(1): 9.
|
| [25] |
Chang KK, Liu LB, Jin LP, et al. IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis [J]. Cell Death Dis, 2017, 8(3): e2666.
|
| [26] |
Jessica E. Miller, Soo Hyun Ahn, et al. Implications of immune dysfunction on endometriosis associated infertility [J]. Oncotarget, 2017, 8(4): 7138-7147.
|
| [27] |
Shu J, Xing L, Ding G, et al. The effect of peritoneal fluid from patients with endometriosis on mitochondrial function and development of early mouse embryos [J]. PLoS One, 2013, 8(12): e82334.
|
| [28] |
Li MQ, Wang Y, Chang KK, et al. CD4＋Foxp3＋ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions [J]. Cell Death Dis, 2014, 5(11): 14-21.
|
| [29] |
Takai E, Taniguchi F, Nakamura K, et al. Parthenolide reduces cell proliferation and prostaglandin E2 [corrected] in human endometriotic stromal cells and inhibits development of endometriosis in the murine model [J]. Fertil Steril, 2013, 100(4): 1170-1178.
|
| [30] |
Wang SW, Sun YM. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (review) [J]. Int J Oncol, 2014, 44(4): 1032-1040.
|
| [31] |
Podgaec S, Barbeiro DF, Gueuvoghlanian-Silva BY, et al. Foxp3 expression in deep rectosigmoid endometriosis lesions and its association with chronic pelvic pain [J]. J Reprod Immunol, 2014, 104(11): 96-99.
|
| [32] |
Jeung I, Cheon K, Kim MR. Decreased cytotoxicity of peripheral and peritoneal natural killer cell in endometriosis [J]. Biomed Res Int, 2016, 2016: 2916070.
|
| [33] |
Acién P, Quereda FJ, Gomez-Torres MJ, et al. GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis [J]. Gynecol Obstet Invest, 2003, 55(1): 96-104.
|
| [34] |
Oda K, Hamanishi J, Matsuo K, et al. Genomics to immunotherapy of ovarian clear cell carcinoma: unique opportunities for management[J]. Gynecol Oncol, 2018, 151(2): 381-389.
|